Key facts
- It has raised $10K; the latest was Later Stage VC in Feb 2026.
- Notable investors include Creative Destruction Lab, European Innovation Council, InnovationQuarter, Delft Enterprises, Graduate Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for SoundCell
- ·The full record, as it builds
Funding rounds
No funding rounds for SoundCell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SoundCell
Developer of a biosensor-based diagnostic platform designed to determine antibiotic effectiveness for infections rapidly. The company's platform offers graphene-based sensing technology, real-time bacterial motion analysis, and compatibility with clinical samples, enabling healthcare providers to identify effective treatments and respond quickly to infections.
- Sector
- Healthcare
- HQ
- Delft, Netherlands
- Founded
- 2022
- Website
- soundcell.nl/
- Ownership
- Privately Held (backing)
SoundCell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SoundCell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SoundCell in its N-PORT filings yet. We sweep new filings monthly.